Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.18
Bid: 52.26
Ask: 52.30
Change: 0.12 (0.23%)
Spread: 0.04 (0.077%)
Open: 52.38
High: 52.90
Low: 52.18
Prev. Close: 52.06
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ECNs - Supreme Court Decision

16 Jun 2016 10:03

RNS Number : 3893B
Lloyds Banking Group PLC
16 June 2016
 

 

  

 

16 June 2016

ENHANCED CAPITAL NOTES - SUPREME COURT DECISION

The Supreme Court has today handed down its decision in respect of the interpretation of certain terms of the Enhanced Capital Notes (ECNs) and found in the Group's favour.

 

The Court held that a Capital Disqualification Event (CDE), as defined in the conditions of the ECNs, has occurred.

 

Throughout the process the Group has sought to balance the interests of all stakeholders and the Group welcomes this decision from the Supreme Court, which confirms the occurrence of a CDE and supports the Group's redemption of all series of ECNs using the Regulatory Call Right earlier this year.

 

- END -

 

 

For further information:

 

Investor Relations

Douglas Radcliffe +44 (0) 20 7356 1571

Group Investor Relations Director

Email: douglas.radcliffe@finance.lloydsbanking.com 

 

 

Corporate Affairs

Matt Smith +44 (0) 20 7356 3522

Head of Corporate Media

Email: matt.smith@lloydsbanking.com 

 

 

FORWARD LOOKING STATEMENTS

This document contains certain forward looking statements with respect to the business, strategy and plans of Lloyds Banking Group and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Lloyds Banking Group's or its directors' and/or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend upon circumstances that will or may occur in the future. Factors that could cause actual business, strategy, plans and/or results (including but not limited to the payment of dividends) to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward looking statements made by the Group or on its behalf include, but are not limited to: general economic and business conditions in the UK and internationally; market related trends and developments; fluctuations in exchange rates, stock markets and currencies; the ability to access sufficient sources of capital, liquidity and funding when required; changes to the Group's credit ratings; the ability to derive cost savings; changing customer behaviour including consumer spending, saving and borrowing habits; changes to borrower or counterparty credit quality; instability in the global financial markets, including Eurozone instability, the potential for one or more countries to exit the Eurozone or European Union (EU) (including the UK as a result of a referendum on its EU membership) and the impact of any sovereign credit rating downgrade or other sovereign financial issues; technological changes and risks to cyber security; natural, pandemic and other disasters, adverse weather and similar contingencies outside the Group's control; inadequate or failed internal or external processes or systems; acts of war, other acts of hostility, terrorist acts and responses to those acts, geopolitical, pandemic or other such events; changes in laws, regulations, accounting standards or taxation, including as a result of further Scottish devolution; changes to regulatory capital or liquidity requirements and similar contingencies outside the Group's control; the policies, decisions and actions of governmental or regulatory authorities or courts in the UK, the EU, the US or elsewhere including the implementation and interpretation of key legislation and regulation; the ability to attract and retain senior management and other employees; requirements or limitations imposed on the Group as a result of HM Treasury's investment in the Group; actions or omissions by the Group's directors, management or employees including industrial action; changes to the Group's post-retirement defined benefit scheme obligations; the provision of banking operations services to TSB Banking Group plc; the extent of any future impairment charges or write-downs caused by, but not limited to, depressed asset valuations, market disruptions and illiquid markets; the value and effectiveness of any credit protection purchased by the Group; the inability to hedge certain risks economically; the adequacy of loss reserves; the actions of competitors, including non-bank financial services and lending companies; and exposure to regulatory or competition scrutiny, legal, regulatory or competition proceedings, investigations or complaints. Please refer to the latest Annual Report on Form 20-F filed with the US Securities and Exchange Commission for a discussion of certain factors together with examples of forward looking statements. Except as required by any applicable law or regulation, the forward looking statements contained in this document are made as of today's date, and Lloyds Banking Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statements. The information, statements and opinions contained in this document do not constitute a public offer under any applicable law or an offer to sell any securities or financial instruments or any advice or recommendation with respect to such securities or financial instruments.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPKKFSXKEEF
Date   Source Headline
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares
7th Mar 20242:29 pmRNSDirector/PDMR Shareholding
6th Mar 20246:08 pmRNSTransaction in Own Shares
6th Mar 20245:55 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSHolding(s) in Company
5th Mar 20245:25 pmRNSTransaction in Own Shares
5th Mar 202412:21 pmRNSPublication of Final Terms
4th Mar 20246:03 pmRNSTransaction in Own Shares
1st Mar 20245:45 pmRNSTransaction in Own Shares
1st Mar 20243:00 pmRNSDirector/PDMR Shareholding
1st Mar 20242:45 pmRNSPublication of Suppl.Prospcts
1st Mar 202411:51 amRNSPublication of Suppl.Prospcts
29th Feb 20246:12 pmRNSTransaction in Own Shares
29th Feb 20245:18 pmRNSTotal Voting Rights
29th Feb 20244:21 pmRNS2023 Form 20F Filed
29th Feb 20242:30 pmRNSTotal Voting Rights
29th Feb 20248:32 amRNS2023 Annual Report and Accounts
29th Feb 20248:32 amRNS2023 Annual Report and Accounts
28th Feb 20245:57 pmRNSTransaction in Own Shares
27th Feb 20245:59 pmRNSTransaction in Own Shares
26th Feb 20246:15 pmRNSTransaction in Own Shares
26th Feb 202411:00 amRNSDirector/PDMR Shareholding
23rd Feb 20246:10 pmRNSTransaction in Own Shares
23rd Feb 202411:50 amRNSPublication of Suppl.Prospcts
23rd Feb 20247:34 amRNSShare Buyback Programme Commences
22nd Feb 20244:13 pmRNS2023 Form 20F Filed
22nd Feb 20247:00 amRNSBoard Changes
22nd Feb 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNS2023 Annual Report and Accounts
20th Feb 20242:05 pmRNSReplacement Block listing Interim Review
20th Feb 20242:00 pmRNSReplacement Block listing Interim Review
15th Feb 20247:00 amRNSBoard Change
31st Jan 20243:56 pmRNSTotal Voting Rights
25th Jan 20245:07 pmRNSBoard Committee Change
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
5th Jan 20241:50 pmRNSPublication of Final Terms
2nd Jan 202412:00 pmRNSBlock listing Interim Review
29th Dec 202310:30 amRNSTotal Voting Rights
18th Dec 20232:30 pmRNSBoard Committee Change
18th Dec 20232:00 pmRNSDirector/PDMR Shareholding
12th Dec 20234:00 pmRNSDirector/PDMR Shareholding
30th Nov 20232:00 pmRNSTotal Voting Rights
20th Nov 20232:00 pmRNSBlock Listing of Shares
10th Nov 20234:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.